Recent Performance of Axogen Inc (AXGN) Stock: A Closer Look

A share price of Axogen Inc [AXGN] is currently trading at $16.82, up 0.54%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AXGN shares have gain 4.67% over the last week, with a monthly amount glided 8.59%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Axogen Inc [NASDAQ: AXGN] stock has seen the most recent analyst activity on March 17, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $30. Previously, Raymond James started tracking the stock with Outperform rating on July 01, 2024, and set its price target to $13. Canaccord Genuity upgraded its rating to a Buy and increased its price target to $15 on May 09, 2022. Guggenheim started tracking with a Buy rating for this stock on October 23, 2020, and assigned it a price target of $24.

Axogen Inc experienced fluctuations in its stock price throughout the past year between $9.22 and $21.00. Axogen Inc [NASDAQ: AXGN] shares were valued at $16.82 at the most recent close of the market.

Analyzing the AXGN fundamentals

Trailing Twelve Months sales for Axogen Inc [NASDAQ:AXGN] were 203.27M which represents 18.26% growth. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.04 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.61.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Axogen Inc [NASDAQ:AXGN] is 4.14. Also, the Quick Ratio is 2.67, while the Cash Ratio stands at 1.04. Considering the valuation of this stock, the price to sales ratio is 3.81, the price to book ratio is 6.86.

Transactions by insiders

Recent insider trading involved DeVinney Erick Wayne, Chief Innovation Officer, that happened on Sep 16 ’25 when 1137.0 shares were sold. Director, Weiler Kathy Johnson completed a deal on Jun 09 ’25 to sell 4073.0 shares. Meanwhile, Director Levine Alan M sold 4073.0 shares on Jun 09 ’25.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.